Diagnos Inc. (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues, announces today the initiation of a clinical trial study with CommonSpirit Health Research Institute, Chattanooga Center for Neurologic Research LLC and conducted at the CommonSpirit Hospital in Chattanooga, to confirm early Proof-of-Concept results that showed a strong potential in… Continue reading Diagnos $ADK $DGNOF Initiates a Clinical Trial Study in the USA for Early Detection and Prevention of Stroke Using it new Application CARA-STROKE
Tag: patients
Theralase “TLT” Discovers Anti-Cancer Memory Response
Theralase Technologies Inc. (CVE:TLT) (OTCBB: TLTFF) announced that in preclinical animal testing, performed at Princess Margaret Cancer Centre, University Health Network, it has discovered that its lead Photo Dynamic Compound (PDC), intended for the destruction of cancer, has demonstrated an ability to render animals immune to repeated exposures of the same cancer.In previous research conducted… Continue reading Theralase “TLT” Discovers Anti-Cancer Memory Response